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1. Introduction  
Stem cells have great potential for use as a regenerative therapy for degenerative diseases, 
such as diabetes or Parkinson’s. However, to create a large-scale and reproducible protocol, 
large homogeneous cell populations are required. For example, it is estimated that to treat 
one patient with stem cell-derived functional beta-cell equivalents for diabetes would 
require approximately 1 billion homogeneous beta-cell equivalents (Docherty et al. 2007). To 
reproducibly expand ESCs to this order remains a major research hurdle. Suspension 
bioreactors offer major advantages over traditional, static culture methods, including the 
ability to monitor and control important bioprocess parameters such as dissolved oxygen, 
pH, and temperature. In addition, for clinical implementation of a stem cell therapy, 
automation associated with bioreactors will aid in compliance with regulatory protocols 
(Martin et al. 2009). Other advantages of suspension bioreactors over traditional (static) cell 
culture methods, include scalability, enhanced oxygen and nutrient transfer, homogeneity, 
and increased reproducibility. However, the use of larger-scale bioreactors (for example, 
greater than 100 mL working volume) incurs significant expenses as considerable amounts 
of media, cells, and other supplies are required. In addition, extensive time and handling is 
necessary to generate enough cells for inoculation. Small-scale bioreactors (less than 100 mL 
working volume) require fewer cells, are more economical, and require less labour than 
larger bioreactors. The use of small-scale bioreactors potentially permits high-throughput 
experimentation to test operating and growth conditions (media components, agitation rate, 
cell density) and the resulting interactions. 
In a suspension bioreactor, cells are suspended in liquid medium which consists of a 
mixture of water, glucose, amino acids and dissolved oxygen, among other factors. As the 
suspension bioreactor is agitated, the environment within the bioreactor is more 
homogeneous than traditional culture environments, such as a T-flask, where gradients 
occur in the static media. The hydrodynamic environment created by agitation of the 
suspension bioreactor is known to influence cell survival. Excessive amounts of shear stress 
can lead to damage to cell membranes (Betts and Baganz 2006) whereas insufficient amounts 
of shear stress can cause excessive agglomeration (Li et al. 2009). In addition, manipulating 
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the amount of shear stress on cells has been found to influence the resulting diameter of 
mammalian neural stem cell aggregates (Sen et al. 2001) which in turn also influences the 
distances through which nutrients must diffuse.  
2. Stem cell culture in suspension bioreactors 
It is well established in literature that stem cells can be cultured in suspension bioreactors 
(Kallos and Behie 1999; Krawetz et al. 2009; Kwon et al. 2003; Niebruegge et al. 2009; 
Schroeder et al. 2005; Youn et al. 2005). As an example, murine embryonic stem cells have 
been successfully expanded in 100 mL suspension bioreactors within specific ranges of 
agitation rates and corresponding shear stresses. The mESCs were expanded over a period 
of 6 days. Three agitation rates were tested: 80, 100 and 120 rpm. mESC expansion was 
found to be greatest at 100 rpm reaching a peak viable cell density of 106 cells/mL. It was 
also observed that aggregate diameters in the 100 rpm bioreactors were smaller than that of 
the 80 rpm bioreactors whereas the 120 rpm bioreactors resulted in excessive cell debris and 
no proliferation indicating substantial damage to the cells (Cormier et al. 2006).  
Cormier et al. also examined the effect of cell culture in suspension bioreactors on 
pluripotency. Immunocytochemistry was examined for several mESC pluripotency markers: 
Oct-4, Nanog and SSEA-1, which are expressed in undifferentiated mESC cells, and 
downregulated once cells differentiate (Murphy and Polak 2002; Tavares et al. 2007). 
Samples were taken from static culture (prior to suspension culture) and on Day 4 of the 
suspension culture (within the exponential growth phase) and positive expression of all 
pluripotency markers were observed in both samples (Cormier et al. 2006).  
mESCs have also been serially passaged in suspension bioreactors (zur Nieden et al. 2007). 
Aggregates were harvested on Day 4 (within the exponential growth phase), dissociated 
into single cells and re-inoculated at a cell density equal to 3.75 × 104 cells/mL. This 
procedure was repeated for seven subsequent passages; static cultures were maintained 
over the same time period. The suspension culture had a cumulative 2.5 billion-fold 
expansion over the 28 day period, whereas a control static culture had a 76.4 trillion fold 
expansion. However, as the static cultures were passaged every two days, there were twice 
as many static passages as suspension passages. Per passage, the suspension culture was 
found to have a 31-fold expansion whereas the static culture had a smaller 10-fold 
expansion. In addition, 37 static culture flasks would be required to obtain the total cell 
number as obtained from one suspension bioreactor (zur Nieden et al. 2007). While the 
amount of static culture flasks could be reduced by using larger static flasks, the 
homogeneity, reproducibility and reduced amount of labour motivate the use of suspension 
bioreactors for clinical applications. 
Suspension bioreactors have been used to produce mesoderm and cardiac cells from hESCs 
however these cells were first cultured under static conditions on a layer of feeder cells and 
transferred into suspension culture after differentiation had begun (Niebruegge et al. 2009). 
The use of feeder cells decreases the amount of reproducibility and increases the risk of 
contamination and immune response; this protocol could not be used for clinical application.  
The expansion of hESCs in a suspension bioreactor has been successful with the addition of 
Rho-associated kinase (ROCK) inhibitor which has been found to diminish dissociation-
induced apoptosis for single cells (Li et al. 2009; Watanabe et al. 2007). Krawetz et al. 
exposed H9 hESCs to ROCK inhibitor for 24 hours and obtained a cell fold expansion of 25 
over 6 days (Krawetz et al. 2009). Kehoe et al. exposed H1 hESCs to ROCK inhibitor for only 
www.intechopen.com
 
Small-Scale Bioreactors for the Culture of Embryonic Stem Cells 75 
30 minutes and obtained a cell fold expansion of 5.6 over 7 days (Kehoe et al. 2009). These 
researchers also used different media for the cell culture. In a 50 mL suspension bioreactor, 
Singh et al. (2010) cultured various hESC lines: hES2, hES3, ESI04 and found that culturing 
the cells in the presence of ROCK and a heat shock treatment resulted in the greatest amount 
of cell survival (60% cell survival with ROCK and heat shock treatment, compared to 2% in 
the control case). It was also found that all three cell lines formed comparably sized 
aggregates and resulted in approximate 2-fold cell expansion per passage. However, Singh 
et al. noted cell line differences in the maintenance of pluripotency within the suspension 
bioreactors; pluripotency markers remained high for the hES2 and hES3 lines, but Oct4, Tra-
160 and SSEA4 down regulated for the ESI049 hESC line (Singh et al. 2010). 
Other research groups have reported successful expansion of hESCs in suspension culture 
where the suspension culture in this case is not a suspension bioreactor but rather a shake 
flask (Amit et al. 2010), low-attachment well plate (Olmer et al. 2010) or in some cases, not 
described (Rezaei Larijani et al. 2011; Steiner et al. 2010). The data obtained from these 
researchers provides valuable information about the hESCs ability to differentiate in 
suspension where hESCs were differentiated to neural cells in suspension (Steiner et al. 
2010) and to neural, cardiomyocytes and hepatocytes in suspension (Rezaei Larijani et al. 
2011). Additionally, the ability of hESCs to maintain stable karyotypes and maintain 
pluripotency in suspension was established (Amit et al. 2010; Olmer et al. 2010; Rezaei 
Larijani et al. 2011; Steiner et al. 2010). However, these cell culture strategies are not 
amenable to substantial scale-up for clinical purposes due to heterogeneity and lack of 
control over bioprocess parameters.  
Another option for suspension culture of hESCs is using microcarriers which provide an 
adherent surface for the cells to grow on. hESCs have been successfully expanded in a long-
term (6 months) suspension culture grown on microcarriers; the cells retained their 
pluripotency (as indicated by > 95% expression levels of SSEA4 and TRA-1-60 markers) 
reaching a cell density twice that of a static culture: 1.6 million cells/mL as opposed to 0.8 
million cells/mL (Oh et al. 2009). However, microcarrier cultures are disadvantageous for 
large scale production since the cells must be dissociated from the surface of the 
microcarrier and/or the microcarrier dissolved before clinical use.  
While the results of hESCs cultured in suspension and in suspension bioreactors are 
promising, there is still substantial research to be performed regarding agitation rates, shear 
stress, and media components before hESCs can be successfully expanded in controlled 
bioprocesses to large clinically meaningful populations. 
3. Small-scale bioreactors 
Small-scale systems have traditionally been used for preliminary research such as screening 
a large number of experimental conditions. However, for process scale up, where the 
biological product obtained for a large-scale operation (5 to 100 L for mammalian cells) is 
equivalent to the small scale bioreactor product; many experiments are required to 
determine desired media components and operating conditions. However, the use of 
standard-scale bioreactors (100 mL working volume) incurs significant cost since 
considerable amounts of media, cells, and other supplies are required. In addition, extensive 
time and handling is necessary to generate enough cells for inoculation. A scalable, small-
scale suspension bioreactor system would require fewer cells, and less labour than was 
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previously possible with larger suspension bioreactors. High‐throughput cell culture 
experiments at a more economical scale could then be performed for culture optimisation 
(Kostov et al. 2001) and allow for factorial experimental design.  
While substantial research has been completed in the area of scaled-up production 
(Baghbaderani et al. 2008; Fernandes-Platzgummer et al. 2011; Garcia-Ochoa and Gomez 
2009; Gilbertson et al. 2006; Park et al. 2010; Youn et al. 2005; Yu et al. 2009) to increase cell 
cultures to clinically meaningful numbers such as the estimated 1 billion cells per patient 
required for stem cell therapy (Docherty et al. 2007), there has been little development in 
scaling down mammalian cell bioreactor systems. Many scaled-down bioreactors in the 
literature have been developed to culture Escherichia coli (bacteria) or Saccharomyces cerevisiae 
(yeast). Some consist of shaken well plate systems (Duetz 2007; Elmahdi et al. 2003; 
Micheletti et al. 2006). In these systems, bacteria and yeast cultures are more mechanically 
srong and thus they can be agitated at substantially higher rates than mammalian cells 
(Betts and Baganz 2006). In addition, surface tension effects are more pronounced in shaken 
systems than in stirred configurations (Betts and Baganz 2006). Recently, many of the small-
scale systems in literature have been changed from initial shaken models to a stirred design 
(Gill et al. 2008; Islam et al. 2007; Kusterer et al. 2008; Micheletti et al. 2006; Weuster-Botz et 
al. 2005). 
There are many inconsistencies in the literature on the definition of a microbioreactor. This 
report will use the definitions of small-scale bioreactors as outlined in Table 1.  
 
Bioreactor Working Volume 
Nanobioreactor < 1  µL 
Microbioreactor 1 ≤ v <  1000 µL 
Minibioreactor 1 ≤ v < 100 mL 
Standard bioreactor 100 ≤ v <  500 mL 
Large bioreactor ≥ 500 mL 
Table 1. Working Volumes of Bioreactors 
Industrial sized bioreactors can reach sizes much greater than 1L, but currently, large 
bioreactors of this size and beyond have not been needed for embryonic stem cell culture. 
3.1 Bacteria and yeast culture in small-scale bioreactors 
There are a number of different small-scale stirred bioreactor systems currently available in 
the literature all of which contain oxygen and pH sensors. The first was developed by the 
Lye group at University College, London. This bioreactor system was designed to be 
geometrically similar to large scale bioreactors, and driven by a miniature turbine impeller. 
They found that to ensure the impeller was submerged in liquid, and to achieve an agitation 
rate of up to 2000 rpm, the bioreactor was restricted to be 100 mL in size. The impeller was 
magnetically driven, and up to 16 reactors could be operated in parallel with continuous on-
line monitoring and control of pH, dissolved oxygen and temperature. The calculated 
maximum specific growth rate (of E. coli) and final biomass concentrations achieved were 
similar between the small-scale bioreactor and a conventional large-scale 2 L bioreactor. The 
group concluded that results obtained from small-scale parallel experiments in the 
miniature bioreactors can thus be converted to large-scale bioreactors (Gill et al. 2008). While 
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this conclusion is valid, the work was performed on a bioreactor which is considered 
standard-sized for lab-scale mammalian cell experimentation, and the bioreactor system 
presented by the Lye group is not suitable for high-throughput analysis. 
A second small-scale bioreactor system was developed by the Weuster-Botz group from 
Technische Universitat, Germany. This minibioreactor system uses a 48-reactor block of 
magnetically stirred bioreactors each one of the order of 10 mL scale. Dissolved oxygen and 
pH are measured by chemical sensors. Sampling and acid or base additions were carried out 
by a robotic liquid handling system with up to 20 µL sampled every 1 to 4 hours. This 
sample was read by a microtitre plate fluorescence reader, in which the optical density was 
correlated to cell density. The growth characteristics of E. coli and S. cerevisiae were similar at 
the 10 mL and 20 L scale (Kusterer et al. 2008). The above system has recently been modified 
with a new impeller for the culture of mycelium forming microorganisms. These 
cultivations are more prominently affected by shear forces than bacteria or yeast cultures as 
shear stress effects the morphology and productivity of these cells (Hortsch et al. 2010). 
Additionally, the culture broth is a non-Newtonian, shear-thinning fluid (Pollard et al. 2002) 
with lower viscosity at higher shear rates which influences mixing, heat and mass transfer 
processes within the bioreactor. The new impeller developed by this group aimed to ensure 
sufficient gas-liquid mass transfer for the cultured Streptomyces tendae. The impeller is a 
vertical, one-sided paddle which distributes power throughout the reactor, resulting in 
consistent viscosity throughout the reactor. 
The 10 mL bioreactors were agitated at 1200 rpm. Reference cultivations were cultured in a 
3L stirred tank bioreactor (impeller speed was equal to 800 rpm) where the power input was 
held constant between the two bioreactor sizes. The production of nikkomycin Z was 
compared between the two scales and it was found that approximately 300 mg L-1 were 
produced at each size scale (Hortsch et al. 2010). However, while these agitation rates are 
lower than that used for bacterial or yeast cultures, they are still much higher than that 
which mammalian cells could sustain. 
A third small-scale bioreactor system was developed by the Rao group of the University of 
Maryland. A 2 mL minibioreactor was developed, and the volumetric mass transfer 
coefficient (kLa) was kept constant from the small-scale bioreactor up to 1 L, based on the 
rational that higher kLa may yield increased cell growth due to oxygen availability, and kLa 
should thus be kept constant for scalability between the two systems. It was observed that 
oxygen depletion patterns between the two systems were similar during exponential 
growth. The total cost of the bioreactor system was less than US$400 (in 2001); the Rao 
group proposes that it seems possible to develop a bioprocess system where many 
bioprocesses can run in parallel (96 or more) for lower cost than a bench scale bioreactor. 
However, the system was magnetically stirred by a stir-bar located on the bottom of the 
vessel (Kostov et al. 2001). This arrangement, with the stir bar free-floating in the system, 
has been found to be detrimental to mESC expansion; it is hypothesized that the stir bar, 
sitting on the bottom of the vessel, effectively crushes the cells as they are pulled underneath 
(Millar 2009).  
The Rao group has also developed an additional minibioreactor with a working volume of 
10 to 35 mL agitated with an impeller, for the cultivation of bacteria and yeast (Harms et al. 
2006). The design of the bioreactor agitation system has not been published other than to 
specify that the small-scale bioreactors are stirred and each well is controlled by an 
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individual stepper motor. The use of an individual motor for each well would provide 
opportunity for agitation rate testing in multiples on a small scale, but not yet to the small 
micro-scale desired in this study. In addition, increasing the number of motors used vastly 
increases the cost and operational complexity of the system. 
A fourth small-scale reactor, developed by the Jensen group at the Massachusetts Institute of 
Technology was also designed for bacteria and yeast culture, and is the smallest stirred 
small-scale reactor to be found in the literature at 0.1 to 1.0 mL in working volume. The most 
recent form of this microbioreactor has the impeller extend upward from the base of the 
reactor; 100 µL volumes were found to replicate the growth kinetics and gene expression 
profiles of E. coli as in a 0.5 L bioreactor (Zhang et al. 2007). While these results are 
promising, an array for parallel experimentation has not yet been developed (a single 
reactor only) and the location of the impeller at the base of the reactor would make 
operation (cleaning and sterilizing) difficult. 
3.2 Mammalian cell culture in small-scale bioreactors 
To date, there has not been any scaled-down stirred, suspension bioreactors published for 
mammalian cell culture. However, there have been developments relating to small-scale 
mammalian cell culture devices to investigate the cell microenvironment (Cimetta et al. 
2009; Figallo et al. 2007; Wu et al. 2006). These devices are not amenable to scaled-up 
production, or high-throughput screening for bioreactor cultivations, since bioreactor 
hydrodynamics are not designed to be similar to a standard bioreactor but they are designed 
rather to study the cell microenvironment. In addition, these systems are perfusion based 
allowing for constant exchange of nutrients for waste; while this is beneficial for cell culture, 
it is in contrast to the batch cultivations of a stirred-tank bioreactor which this chapter has 
focused on.  
Small-scale hollow-fiber devices for use as a bioartificial liver are also being developed 
(Gramer and Britton 2002; Rodriguez et al. 2008). However, these reactors are designed for 
cell product secretion, and not for cell expansion, and again are not amenable to scaled-up 
expansion of stem cells.  
There have been developments for mammalian cell culture in small-scale shaken 
bioreactors. Chinese Hamster Ovary (CHO) cells were cultivated in a small-scale shaken 
bioreactor, equipped with a ventilation cap. The small-scale bioreactor has a footprint of a 24 
well-plate, and each vial has a working volume of 6 mL (Isett et al. 2007). The cell growth 
and metabolite profiles in th 6 mL bioreactor were found to be similar when compared to a 
large-scale 2 L bioreactor culture where 85% of the viable cell density of CHO cells cultured 
in the small-scale bioreactor was within 20% of the viable cell density of CHO cells cultured 
in the 2L bioreactor (Chen et al. 2008). While this is a promising result, the size scale remains 
a barrier to high throughput screening, and no engineering calculations were done to show 
a comparison of the bioreactor hydrodynamics between the two size scales.  
Girard et al. (2001) also cultured CHO cells in a small-scale shaken bioreactor; the cells were 
cultured in the wells of a twelve-well microtiter plate and shaken on a rotational shaker 
plate. As the well plates are stackable, several hundred small-scale bioreactor experiments 
were able to be reproducibly completed. Cell density was measured with the use of 
fluorescence measurements, which allows for non-invasive sampling. In this study, the 
formation of cellular aggregates was compared between the shaken well plate small-scale 
bioreactor (2 mL working volume) and a 3 L stirred bioreactor and the resulting cell 
aggregate size was found to be comparable. The two systems were also compared with 
respect to production of protein where the small-scale bioreactor resulted in double the 
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production of protein from the standard bioreactor. However, the results also indicated that 
evaporation was a problem within the small-scale bioreactor which led to inconsistencies in 
the results (Girard et al. 2001).  
CHO cells have also been cultivated in a 700 µL microbioreactor; cultures were inoculated in 
small chambers of a plastic card with diffusible walls for oxygen and carbon dioxide mass 
transfer. The cards were then rotated. The cell culture behaved similarly to a 3 L large-scale 
bioreactor, where the correlation factor, R2, between the two scales for the resulting viable 
cell density was equal to 0.84. In addition, the small-scale bioreactor was used to analyse the 
process in a high throughput manner; finding that supplementing the media substantially (p 
< 0.05) affected the cells resulting in a higher cell mass. However, due to the small volumes 
used, Legmann et al. noticed significant differences in the cell counts from the 
microbioreactors (Legmann et al. 2009).  
By using agitation induced by thermal convection, a 250 μL microbioreactor has been 
developed for expansion of human hematopoietic stem cells. The temperature gradient 
within the microbioreactor was small ranging from 36.0 to 36.015°C, where the heat source 
was provided at the base of the reactor. This resulted in temperatures suitable for 
mammalian cell culture. Experimental tests comparing the microbioreactor culture to a static 
control resulted in no statistically significant effect on the cell proliferation rate (Luni et al. 
2010). Thus, while this microbioreactor yields successful cell expansion, it does not result in 
the large degree of enhanced cell expansion seen in suspension bioreactors as compared to 
static controls such as the 31-fold expansion observed in a standard 100 mL bioreactor as 
compared to 10-fold expansion in a static control (Cormier et al. 2006). Thermal convection 
mixing may provide a cell culture environment not significantly different from the static 
control. In addition, this system would be difficult to scale up because increasing large 
temperature gradients would be required which could be higher than viability threshold 
temperatures for mammalian cells. 
3.3 Small-scale bioreactors operating in parallel 
While the creation of a small-scale bioreactor for cell culture is indeed beneficial for 
research, small-scale bioreactors must be capable of operating in parallel with many other 
small-scale bioreactors for high-throughput experimentation and factorial analysis. The 
degree of parallel application found in small-scale bioreactors throughout the literature is 
presented in Table 2. Most small-scale bioreactors found in the literature are not yet 
amenable to high-throughput analysis while maintaining consistent hydrodynamic 
environments as a stirred standard scale bioreactor.  
 
Research Bioreactor Scale 
Number of Bioreactors  
Operating in Parallel 
Gill et al. 2008 Standard (100 mL) 4-16 
Kusterer et al. 2008 Minibioreactor (12 mL) 48 
Isett et al. 2007 Minibioreactor (6 mL) 24 
Girard et al. 2001 Minibioreactor (2 mL) 12-144 
Legmann et al. 2009 Microbioreactor (700 μL) 180 
Table 2. Parallel Application of Small-Scale Bioreactors. The number of bioreactors at each 
size scale is presented.  
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Applying parallel operation to bioreactors from a single prototype results in a number of 
complications. For example, Gill et al. found that the magnetically agitated bioreactor 
impeller design must be altered when creating a parallel application to avoid interacting 
magnetic fields. Due to the impeller design changes, the researchers found that the 
bioreactors must be agitated at speeds greater than 1000 rpm to maintain a homogeneous 
gas bubble distribution within the culture media (Gill et al. 2008). Maintaining sterility has 
also been noted as an obstacle to parallelization, in particular during culture sampling. 
Kusterer et al. found that washing the components encountering sampling needles with a 
mixture of 70% ethanol (v/v) and 20% acetone (v/v) to be sufficient (Kusterer et al. 2008). 
However, cross-contamination between samples must also be avoided where each vessel 
must be treated as an individual sample with individual sampling ports. Girard et al. 
accomplished this through measuring cell growth via green fluorescent protein expressing 
cells and a fluorescence plate reader (Girard et al. 2001). Success with this method is thus 
dependent on a green fluorescent protein expressing cell line. Isett et al. also used 
fluorescence to monitor dissolved oxygen level (Isett et al. 2007). While Legmann et al. were 
able to successfully culture the mammalian cells in parallel microbioreactors,  
the hydrodynamics of the microbioreactor developed would not relate to a standard 
bioreactor. 
3.4 Hydrodynamic environment of small-scale bioreactors 
The hydrodynamic environment in a bioreactor is known to be a function of the bioreactor 
and impeller geometries, agitation rate, medium viscosity and volume (Flickinger and Drew 
1999; King and Miller 2007; Marks 2003; Sen et al. 2002). When scaling reactors up, from lab 
scale to an industrial scale, it is common to hold several parameters constant to maintain a 
consistent hydrodynamic environment. This method may also be used for scaling down the 
size of reactors. It is common to maintain dimensional similarity (Flickinger and Drew 1999) 
such as a liquid height to reactor diameter ratio. However, these calculations do not 
consider the effect of shear stress on mammalian cells. These cells are very sensitive to shear 
stress due to the absence of a cell wall; high agitation rates can adversely affect mammalian 
cell growth (Betts and Baganz 2006). 
While research results from the literature suggest small-scale bioreactors as potential 
technology for use in high throughput screening (Barrett et al. 2010; Betts and Baganz 2006; 
Kumar et al. 2004) and cells cultured in small-scale reactors have reached cell densities 
similar to that of large-scale bioreactors (Gill et al. 2008; Kusterer et al. 2008; Zhang et al. 
2007), there remains a knowledge gap of the fluid behaviour between the two scales. For 
example, correlations and dimensionless numbers used to characterize systems at the large-
scale may not be applicable at the small scale. The Reynolds number, often used to 
characterize fluid systems, has been found to not be applicable at the micro-scale (Betts et al. 
2006; Micheletti and Lye 2006; Vallejos et al. 2006). In addition, shear stress has been found 
to be a critical factor to maintaining cell cultures in suspension in bioreactors (Sen et al. 
2001). The maximum shear stress on an aggregate in suspension is calculated as a function 
of fluid density and power dissipated per unit mass (Cherry and Kwon 1990; Sen et al. 2002) 
which is in turn a function of the Power Number. A correlation between the Power Number, 
Reynold’s Number, and the reactor geometry has been developed (Nagata 1975). The 
Reynold’s Number and Power Number are dimensionless numbers which act as a 
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representation of physical forces. The Reynold’s Number (Re) is a ratio of inertial to viscous 
forces, and is calculated as: 
               ܴ݁ ൌ ఘ௎஽ఓ           (1) 
Where  is the fluid density (kg/m3), U is the fluid velocity (m/s), D is a characteristic 
length of the system (m) and  is the fluid viscosity (Pa*s). The Power Number relates the 
resistance force to the intertial force, and is calculated for a reactor system as follows, using 
the shear stress within the system.  
The maximum shear stress for a suspended sphere (aggregate) in turbulence can be found 
from the following equation (Cherry and Kwon 1990; Sen et al. 2002): 
              ߬௠௔௫ ൌ ͷ.͵͵ߩ√ߝߴ   (2) 
where ߬௠௔௫  is the maximum shear stress on an aggregate (Pa), and  is the power dissipated 
per unit mass (m2/s3), which is calculated as: 
       ߝ ൌ ௉௏ಽఘ     (3) 
where P is the power consumed (kg m2/s3), and VL is the liquid volume (m3). The power 
consumed can be calculated as: 
  ܲ ൌ ேܲܰଷܦହߩ   (4) 
 
where PN is the Power Number (dimensionless). The power number has been correlated to 
be a function of the Reynolds number and the physical properties of the bioreactor. The 
empirical correlation is as follows for an unbaffled tank with paddle impellers (Nagata 
1975): 
      ேܲ ൌ ௄భோ௘ ൅ ܭଶ ቂଵ଴యାଵ.ଶோ௘బ.లలଵ଴యାଷ.ଶோ௘బ.లలቃ௄ర   (5) 
where  
    ܭଵ ൌ ͳͶ ൅ ௐ஽೟ ൤͸͹Ͳ ቀ஽೔஽೟ െ Ͳ.͸ቁଶ ൅ ͳͺͷ൨  (6) 
 ܭଶ ൌ ͳͲ௄య   (7) 
 ܭଷ ൌ ͳ.͵ െ Ͷ ቂௐ஽೟ െ Ͳ.ͷቃଶ െ ͳ.ͳͶ ஽೔஽೟    (8) 
 ܭସ ൌ ͳ.ͳ ൅ Ͷௐ஽೟ െ ʹ.ͷ ቂ஽೔஽೟ െ Ͳ.ͷቃଶ െ ͹ ቂௐ஽೟ቃସ  (9) 
 
 
where W is the impeller width (m),  Dt is the tank diameter (m) and Di is the impeller 
diameter (m).  
When calculations are performed with these correlations to try to determine the shear forces 
on cells within the small-scale bioreactors, the resulting agitation rate needed to maintain 
www.intechopen.com
 
Embryonic Stem Cells – Basic Biology to Bioengineering 82
the same shear as present in the larger bioreactor is much too high to sustain mammlian cell 
growth. Specifically, these correlations strongly depend on the Reynolds number. The use of 
a specific Reynolds number as a guide for the transition from laminar to turbulent flow has 
been found inapplicable to small-scale systems such as a microbioreactor (Betts et al. 2006; 
Micheletti and Lye 2006; Vallejos et al. 2006). At larger scales, the Reynold’s number clearly 
represents the transition from laminar to turbulent flow. In addition, as these correlations 
were developed for a large-scale reactor, they may also not be applicable on a very small-
scale.  
3.5 Oxygen environment in small-scale bioreactors 
Typically, stem cell bioreactors use surface aeration to supply oxygen to the suspended cells. 
The surface area to volume ratio in smaller bioreactors is much larger than the standard 100 
mL bioreactors, as shown in Table 3. For embryonic stem cells in suspension culture, the 








Volume (m3) 1.00E-04 2.50E-07 
Surface Area (m2) 2.68E-03 3.12E-05 
Surface Area/Volume (m-1) 2.68E+01 1.25E+02 
 
 
Table 3. Surface area to volume ratio of the standard 100 mL bioreactor and an example 
microbioreactor. 
The following calculations were performed to characterize the mass transfer of oxygen to 
mESCs in a 250 L microbioreactor. The oxygen consumption rate of mESCs in suspension 
has been previously measured (zur Nieden et al. 2007). Assuming a peak cell density of 106 
cells/mL and a 250 L working volume, the peak consumption rate of oxygen of the cells in 
a microbioreactor vial can be determined. A total vessel volume of 1 mL is assumed. By 
using the ideal gas law, the amount of oxygen in the headspace (0.75 mL) is equal to 2.95x10-
5 mol (0.94 mg). Assuming no oxygen transfer from the surrounding environment, where 
the oxygen in the headspace is the only oxygen available to the cells, and knowing the total 
oxygen consumption of the microbioreactor (Table 4), the amount of time required for the 
oxygen in the headspace to completely deplete was found to be 34 days, given a constant 
cell density of 106 cells/mL. While it is unlikely that the cells would remain at a constant cell 
density, this density is the maximum found in standard 100 mL bioreactors, and thus 
represents a worst case scenario. It is more likely that the cell density would initially begin 
at a much smaller value, and then as the cells expanded the cell density would increase to 
106 cells/mL. In addition, as the microbioreactor vial would be opened much more 
frequently than this for sampling or media changes, there is thus an abundant supply of 
oxygen available to the cells.  
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Description Value 
Specific Oxygen Consumption Rate 4 x 10-17  ௠௢௟ ைమ௖௘௟௟∙௦  
Cell Density 106 cells/mL 
Media Volume 0.25 mL 
Total Cells 2.5 x 105 cells 
Total Oxygen Consumption 1 x 10-11  ௠௢௟ ைమ௦  
Table 4. Oxygen consumption by murine embryonic stem cells in a microbioreactor. The cell 
density is assumed to be the peak cell density found by Cormier et al. 2006 and the oxygen 
consumption rate is as determined by zur Nieden et al. 2007.  
The above calculations assume no mass transfer resistance from the bulk gas, through the 
liquid media to the cells, and that the consumption of oxygen by the cells is the limiting 
step. To instead consider the mass transfer of oxygen from the headspace to the liquid 
media as the limiting step, the following equation may be used to calculate the oxygen 
transfer rate: 
   ܱܴܶ ൌ ݇௅ܽሺܥ௦௔௧ െ ܥ஻ሻ   (10) 
Where ݇௅ܽ is the volumetric mass transfer coefficient (h-1), ܥ௦௔௧ is the saturation 
concentration of oxygen in the liquid (mol/L) and C୆ is the steady state bulk concentration 
of oxygen in the liquid (mol/L). The value for the mass transfer coefficient was the same as 
used by Millar (2009) (k୐a  = 2h-1). The solubility of oxygen (from standard air) in water 
used was Cୱୟ୲ = 2.5 x 10-4 mol/L or 8 mg/L (Lenntech 2009). The steady state bulk 
concentration was calculated using a mass balance, and found to be equal to 8.85 x 10-6 
mol/L (0.28 mg/L). With these values, an oxygen transfer rate of 4.82 x 10-4 mol/Lh was 
found. Using this oxygen transfer rate, in combination with the amount of oxygen in the 
headspace calculated earlier in this section (2.95x10-5 mol), it was calculated that with the 
mass transfer of oxygen as the limiting step, there is enough oxygen in the microbioreactor 
to supply the media with oxygen for 244 hours (10 days). This value, while smaller than that 
found when the cell consumption was considered the limiting step, is still long enough for 
cell culture experiments, where cell counts are normally taken once per day, where the 
oxygen supply to the headspace would then be replenished.  
Thus for the majority of cell culture experiments, a closed microbioreactor system provides a 
sufficient supply of oxygen. For long term experiments, or if cell samples were not taken 
more frequently than once per week, an oxygen supply may need to be considered as an 
alternative design. 
4. Conclusions  
Embryonic stem cells are considered to be a source of cells with tremendous potential for 
regenerative medicine, as they are capable of self-renewal and can differentiate into any cell 
type. The bioprocessing of these cells (i.e. creating reliable protocols for cell expansion and 
differentiation) is a critical component of developing therapies ready for clinical 
implementation. Suspension bioreactors are understood to be a scalable, reproducible and 
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reliable method for cell expansion in the biotechnology industry. It is well established that a 
small-scale bioreactor system would be beneficial for stem cell research. Microbioreactor 
systems available in the literature, primarily developed for bacterial and yeast cultures, 
were reviewed and the applications for mammalian, or stem cell cultures were considered. 
However, the fluid environment at this scale remains largely uncharacterised, and 
bioreactor scale-down for cell culture has been shown to not be a linear process. 
Hydrodynamic studies and modeling of the shear and mass transfer environment at this 
small-scale would benefit this field in the development of a small-scale bioreactor applicable 
for embryonic stem cell expansion and differentiation.  
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